Akèy › Gliyosakòm
Etid klinik pou Gliyosakòm ap rekrite nan Etazini
11 etid pou Gliyosakòm ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07301268MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT03896568ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07089641A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Ap rekriteFaz 1
Laj 19 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05698524Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06934889HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Ap rekriteFaz 1
36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
Ap rekriteFaz 1
Laj 12 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT04991870Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Feb 4, 2026 · NCT05756985Study of Pembrolizumab and M032 (NSC 733972)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jan 22, 2026 · NCT05084430Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jan 12, 2026 · NCT05465954Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT04541082Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.